Twist Bioscience Corporation (TWST) Free cash flow 2017–2025
Twist Bioscience Corporation (TWST) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$75.6MFY2025 · since FY2017: -$57.9M → -$75.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$75.6M | -9.3% |
| FY2024 | -$69.2M | +59.4% |
| FY2023 | -$170.3M | +24.7% |
| FY2022 | -$226.2M | -62.4% |
| FY2021 | -$139.3M | +8.4% |
| FY2020 | -$152.1M | -48.1% |
| FY2019 | -$102.7M | -47.0% |
| FY2018 | -$69.9M | -20.7% |
| FY2017 | -$57.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice